Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Joy

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Advances in Chronic Kidney Disease|March 17, 2016
Role of Pharmacogenomics in Kidney Disease and InjuryLinda Awdishu, Melanie S Joy
Cardiology|November 3, 2015
Authors' ReplyParijat S Joy, Gagan Kumar
The Annals of Pharmacotherapy|October 11, 2007
Nephrology pharmacy: historical reflections and future challengesMelanie S Joy, Gary R Matzke
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemiaMelanie S Joy, William F Finn,
Current Medical Research and Opinion|June 23, 2005
A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysisWilliam F Finn, Melanie S Joy,
Therapeutic Drug Monitoring|August 26, 2010
Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritisWai-Johnn Sam, Melanie S Joy
The American Journal of Physiology|March 19, 2010
Modification of respiratory movements by vagal stimulationH V RICE, M S JOY
Journal of Microscopy|February 28, 2006
Scanning electron microscope imaging in liquids - some data on electron interactions in waterD C Joy, C S Joy
ANNA Journal|November 5, 1998
Glycosylated hemoglobin in the care of patients with diabetes mellitusP H Nachman, M S Joy
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2024
Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney InjuryLauren E Thompson, Melanie S Joy
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Advances in Chronic Kidney Disease|March 17, 2016
Role of Pharmacogenomics in Kidney Disease and InjuryLinda Awdishu, Melanie S Joy
Cardiology|November 3, 2015
Authors' ReplyParijat S Joy, Gagan Kumar
The Annals of Pharmacotherapy|October 11, 2007
Nephrology pharmacy: historical reflections and future challengesMelanie S Joy, Gary R Matzke
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemiaMelanie S Joy, William F Finn,
Current Medical Research and Opinion|June 23, 2005
A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysisWilliam F Finn, Melanie S Joy,
Therapeutic Drug Monitoring|August 26, 2010
Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritisWai-Johnn Sam, Melanie S Joy
The American Journal of Physiology|March 19, 2010
Modification of respiratory movements by vagal stimulationH V RICE, M S JOY
Journal of Microscopy|February 28, 2006
Scanning electron microscope imaging in liquids - some data on electron interactions in waterD C Joy, C S Joy
ANNA Journal|November 5, 1998
Glycosylated hemoglobin in the care of patients with diabetes mellitusP H Nachman, M S Joy
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2024
Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney InjuryLauren E Thompson, Melanie S Joy
Pageof 19